Goliath Resources (TSX-V:GOT) Announces Results of Annual and Special Meeting

TORONTO, Ontario — January 15, 2026 — Leads & Copy —Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (Frankfurt: B4IF) has announced the results of its annual and special meeting of shareholders held January 14, 2026.

According to the company, all items of business tabled at the Meeting were approved by the requisite majorities, including the re-election of Roger Rosmus, Graham Warren, Wayne Isaacs and Rein Turna as directors; the re-appointment of McGovern Hurley LLP as auditor; the re-approval of the omnibus equity incentive plan; certain amendments to the Plan approved by disinterested shareholders; and the approval of the consolidation of outstanding common shares on the basis of one (new) for up to seven (old) Common Shares.

Despite shareholder approval of the Consolidation, the Board of Directors has chosen not to proceed.

Meeting materials, including the management information circular dated November 30, 2025, can be found on www.SEDARPLUS.ca and the company’s website.

Goliath Resources is an explorer of precious metals projects in the Golden Triangle of Northwestern British Columbia. It says that all projects are in high quality geological settings and geopolitical safe jurisdictions amenable to mining in Canada. Goliath is a member and active supporter of CASERM, a collaborative venture between Colorado School of Mines and Virginia Tech. Goliath recently completed a drill campaign for a total of 64,364 meters in 2025 and has assays pending for 70 gold only holes and 110 gold equivalent holes. It is fully funded for a drill program in 2026.

The Company’s key strategic cornerstone shareholders include Crescat Capital, a Global Commodity Group (Singapore), McEwen Inc. (NYSE: MUX) (TSX: MUX), Waratah Capital Advisors, Rob McEwen, Eric Sprott and Larry Childress.

Mr. Roger Rosmus
Founder and CEO Tel: +1.416.488.2887
roger@goliathresources.com

Source: Goliath Resources Limited

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.